As of 2025-10-27, the Relative Valuation of Iovance Biotherapeutics Inc (IOVA) is (14.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.25 USD, the upside of Iovance Biotherapeutics Inc based on Relative Valuation is -760.9%.
The range of the Relative Valuation is (14.81) - (14.94) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 13.9x | 13.8x |
| Forward P/E multiples | 13.7x - 13.9x | 13.8x |
| Fair Price | (14.81) - (14.94) | (14.87) |
| Upside | -758.0% - -763.8% | -760.9% |
| Date | P/E |
| 2025-10-17 | -2.02 |
| 2025-10-16 | -2.08 |
| 2025-10-15 | -2.08 |
| 2025-10-14 | -1.97 |
| 2025-10-13 | -1.99 |
| 2025-10-10 | -1.95 |
| 2025-10-09 | -2.03 |
| 2025-10-08 | -2.11 |
| 2025-10-07 | -2.02 |
| 2025-10-06 | -2.05 |
| 2025-10-03 | -2.17 |
| 2025-10-02 | -2.09 |
| 2025-10-01 | -2.05 |
| 2025-09-30 | -2.01 |
| 2025-09-29 | -2.07 |
| 2025-09-26 | -1.96 |
| 2025-09-25 | -1.87 |
| 2025-09-24 | -1.97 |
| 2025-09-23 | -1.92 |
| 2025-09-22 | -1.97 |
| 2025-09-19 | -1.90 |
| 2025-09-18 | -2.04 |
| 2025-09-17 | -2.06 |
| 2025-09-16 | -2.13 |
| 2025-09-15 | -2.11 |
| 2025-09-12 | -2.11 |
| 2025-09-11 | -2.25 |
| 2025-09-10 | -2.21 |
| 2025-09-09 | -2.20 |
| 2025-09-08 | -2.21 |
| 2025-09-05 | -2.31 |
| 2025-09-04 | -2.04 |
| 2025-09-03 | -2.05 |
| 2025-09-02 | -2.03 |
| 2025-08-29 | -2.07 |
| 2025-08-28 | -2.07 |
| 2025-08-27 | -2.25 |
| 2025-08-26 | -2.27 |
| 2025-08-25 | -2.35 |
| 2025-08-22 | -2.50 |
| 2025-08-21 | -2.36 |
| 2025-08-20 | -2.35 |
| 2025-08-19 | -2.41 |
| 2025-08-18 | -2.32 |
| 2025-08-15 | -2.37 |
| 2025-08-14 | -2.27 |
| 2025-08-13 | -2.27 |
| 2025-08-12 | -2.07 |
| 2025-08-11 | -1.83 |
| 2025-08-08 | -1.96 |